Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha IVF Group BhdXKLS:0303 49 3-Year RORE % is 81.82 as of Feb. 2026. GuruFocus rates XKLS:0303 with a GF Score™ of 49/100. Among 603 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks better than 89.88% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Alpha IVF Group Bhd's 3-Year RORE % for the quarter that ended in Feb. 2026 was 81.82%.
The industry rank for Alpha IVF Group Bhd's 3-Year RORE % or its related term are showing as below:
XKLS:0303's 3-Year RORE % is ranked better than 89.88% of 603
companies
in the Healthcare Providers & Services industry
Industry Median: 0.07
vs XKLS:0303: 81.82
Alpha IVF Group Bhd (XKLS:0303) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Alpha IVF Group Bhd 3-Year RORE % Related Terms
Alpha IVF Group Bhd 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Alpha IVF Group Bhd's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0303 vs HCA, THC, DVA: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha IVF Group Bhd 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Alpha IVF Group Bhd's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Feb. 2026 and 3-year before.
Alpha IVF Group Bhd (XKLS:0303) has a 3-Year RORE % of 81.82 as of Feb. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Alpha IVF Group Bhd and its competitors. According to the industry distribution chart, Alpha IVF Group Bhd ranks #61 out of 603 companies in the Healthcare Providers & Services industry, placing it in the top 10.1%.
Is Alpha IVF Group Bhd's 3-Year RORE % too high?
Alpha IVF Group Bhd's current 3-Year RORE % is 81.82. The Healthcare Providers & Services industry median 3-Year RORE % is 0.07. Alpha IVF Group Bhd's value of 81.82 is 116785.7% above this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #61 out of 603 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha IVF Group Bhd has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #61 out of 603 companies for 3-Year RORE %. This places Alpha IVF Group Bhd in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.07. Alpha IVF Group Bhd's value of 81.82 is 116785.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.07, based on 603 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current 3-Year RORE % of 81.82 is 116785.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Alpha IVF Group Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current 3-Year RORE % is 81.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current 3-Year RORE % of 81.82. The current 3-Year RORE % is 81.82 and 116785.7% above the Healthcare Providers & Services industry median of 0.07. Alpha IVF Group Bhd's overall GF Score™ is 49/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current 3-Year RORE % is 81.82 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
49GF Score
Get the complete analysis for XKLS:0303
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0303 has been successfully added to your 
